Larvol Delta - Anifrolumab-Treatment-Prevents-LongTerm-Oral-CorticosteroidRelated-Ocular-and-Musculoskeletal-Organ-Damage-Accrual-Compared-With-RealWorld-Standard-of-Care-in-Patients-With-Systemic-Lupus-Erythematosus-Findings-From-the-LASER-Study

Saphnelo (anifrolumab-fnia) - AstraZeneca

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898725&mode=presInfo

Zahi Touma, MD, PhD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next